Alpine Immune Sciences Secures $48,000,000 Series A Financing Round

  • Feed Type
  • Date
    6/14/2016
  • Company Name
    Alpine Immune Sciences
  • Mailing Address
    600 Stewart St. Seattle, WA 98101 USA
  • Company Description
    Alpine Immune Sciences (AIS) was founded in 2015 and seed funded by Alpine BioVentures. AIS is focused on developing novel protein – based immunotherapies using its proprietary variant immunoglobulin domain (vIgD™) platform technology.
  • Website
    http://www.alpineimmunesciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $48,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    We believe this significant funding, along with our collective expertise, will enable us to discover and develop clinically meaningful and transformative therapies for patients.
  • M&A Terms
  • Venture Investor
    OrbiMed
  • Venture Investor
    Frazier Healthcare Partners
  • Venture Investor
    Alpine Technology Fund

Trending on Xconomy